Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis.

PubWeight™: 1.69‹?› | Rank: Top 3%

🔗 View Article (PMC 2863870)

Published in J Clin Microbiol on March 19, 2010

Authors

Marcela Zozaya-Hinchliffe1, Rebecca Lillis, David H Martin, Michael J Ferris

Author Affiliations

1: The Research Institute for Children, Children's Hospital, Department of Pediatrics and Department of Internal Medicine, Louisiana State University Health Sciences Center, 200 Henry Clay Ave., New Orleans, LA 70118, USA.

Articles citing this

Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS One (2012) 2.79

The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women. Sex Transm Infect (2011) 2.19

Exploring the diversity of Gardnerella vaginalis in the genitourinary tract microbiota of monogamous couples through subtle nucleotide variation. PLoS One (2011) 2.06

Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol (2010) 1.89

Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection. J Infect Dis (2013) 1.56

The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS One (2014) 1.43

At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners AB-1. Proc Natl Acad Sci U S A (2010) 1.30

Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome (2013) 1.28

Composition of the vaginal microbiota in women of reproductive age--sensitive and specific molecular diagnosis of bacterial vaginosis is possible? PLoS One (2013) 1.21

Understanding vaginal microbiome complexity from an ecological perspective. Transl Res (2012) 1.19

Bacterial vaginosis (BV) candidate bacteria: associations with BV and behavioural practices in sexually-experienced and inexperienced women. PLoS One (2012) 1.16

Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women. ISME J (2014) 1.14

Inerolysin, a cholesterol-dependent cytolysin produced by Lactobacillus iners. J Bacteriol (2010) 1.13

The microbiota of the vagina and its influence on women's health and disease. Am J Med Sci (2012) 1.11

More than meets the eye: associations of vaginal bacteria with gram stain morphotypes using molecular phylogenetic analysis. PLoS One (2013) 1.07

Characterization of the vaginal micro- and mycobiome in asymptomatic reproductive-age Estonian women. PLoS One (2013) 1.07

Longitudinal study of the dynamics of vaginal microflora during two consecutive menstrual cycles. PLoS One (2011) 1.06

Longitudinal qPCR study of the dynamics of L. crispatus, L. iners, A. vaginae, (sialidase positive) G. vaginalis, and P. bivia in the vagina. PLoS One (2012) 1.06

Diversity of cervicovaginal microbiota associated with female lower genital tract infections. Microb Ecol (2011) 1.01

Commensal bacteria modulate innate immune responses of vaginal epithelial cell multilayer cultures. PLoS One (2012) 1.01

Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front Physiol (2015) 1.00

The microbiota of the human genitourinary tract: trying to see the forest through the trees. Trans Am Clin Climatol Assoc (2012) 0.98

Development and validation of a semiquantitative, multitarget PCR assay for diagnosis of bacterial vaginosis. J Clin Microbiol (2012) 0.97

Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses. BMC Infect Dis (2011) 0.96

Fluorescence in situ Hybridization method using Peptide Nucleic Acid probes for rapid detection of Lactobacillus and Gardnerella spp. BMC Microbiol (2013) 0.96

Insights into the CRISPR/Cas system of Gardnerella vaginalis. BMC Microbiol (2012) 0.92

Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis. PLoS One (2013) 0.92

Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis. Antimicrob Agents Chemother (2014) 0.92

The Human Microbiome during Bacterial Vaginosis. Clin Microbiol Rev (2016) 0.91

Rapid and Profound Shifts in the Vaginal Microbiota Following Antibiotic Treatment for Bacterial Vaginosis. J Infect Dis (2015) 0.91

Vaginal microbiome in women from Greenland assessed by microscopy and quantitative PCR. BMC Infect Dis (2013) 0.91

S1-Guideline on Bacterial Vaginosis in Gynecology and Obstetrics: Long version - AWMF Guideline, registration no. 015/028, July 2013 Langfassung - AWMF-Register Nr. 015/028, Juli 2013. Geburtshilfe Frauenheilkd (2014) 0.89

Differences in vaginal lactobacilli composition of Iranian healthy and bacterial vaginosis infected women: a comparative analysis of their cytotoxic effects with commercial vaginal probiotics. Iran Red Crescent Med J (2013) 0.88

Identification and characterization of bacterial vaginosis-associated pathogens using a comprehensive cervical-vaginal epithelial coculture assay. PLoS One (2012) 0.86

Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus. Appl Environ Microbiol (2013) 0.85

Making inroads into improving treatment of bacterial vaginosis - striving for long-term cure. BMC Infect Dis (2015) 0.84

Efficacy of rifaximin vaginal tablets in treatment of bacterial vaginosis: a molecular characterization of the vaginal microbiota. Antimicrob Agents Chemother (2012) 0.84

Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis. Eur J Clin Microbiol Infect Dis (2015) 0.84

The changing landscape of the vaginal microbiome. Clin Lab Med (2014) 0.84

A multiplex real-time PCR assay for routine diagnosis of bacterial vaginosis. Eur J Clin Microbiol Infect Dis (2015) 0.81

Development and Validation of a Highly Accurate Quantitative Real-Time PCR Assay for Diagnosis of Bacterial Vaginosis. J Clin Microbiol (2016) 0.81

Characterization of the vaginal microbiota among sexual risk behavior groups of women with bacterial vaginosis. PLoS One (2013) 0.81

Relationship of Specific Bacteria in the Cervical and Vaginal Microbiotas With Cervicitis. Sex Transm Dis (2015) 0.81

Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis. Microbiome (2016) 0.80

Divergences in gene repertoire among the reference Prevotella genomes derived from distinct body sites of human. BMC Genomics (2015) 0.78

The Vaginal Microbiome: Current Understanding and Future Directions. J Infect Dis (2016) 0.77

Association between BVAB1 and high Nugent scores among women with bacterial vaginosis. Diagn Microbiol Infect Dis (2014) 0.76

Progresses in vaginal microflora physiology and implications for bacterial vaginosis and candidiasis. Womens Health (Lond Engl) (2016) 0.75

Inhibition of Staphylococcus aureus by lysostaphin-expressing Lactobacillus plantarum WCFS1 in a modified genital tract secretion medium. Appl Environ Microbiol (2011) 0.75

Development of a composite measure of product adherence, protocol compliance, and semen exposure using DNA and protein biomarkers for topical HIV prevention studies. PLoS One (2014) 0.75

Expanding the UniFrac Toolbox. PLoS One (2016) 0.75

Genomic Comparisons of Lactobacillus crispatus and Lactobacillus iners Reveal Potential Ecological Drivers of Community Composition in the Vagina. Appl Environ Microbiol (2016) 0.75

Comparative analysis of vaginal microbiota sampling using 16S rRNA gene analysis. PLoS One (2017) 0.75

Prevalence and distribution of Gardnerella vaginalis subgroups in women with and without bacterial vaginosis. BMC Infect Dis (2017) 0.75

Articles cited by this

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31

The Ribosomal Database Project (RDP-II): sequences and tools for high-throughput rRNA analysis. Nucleic Acids Res (2005) 24.85

Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol (1991) 20.49

Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med (1983) 16.63

Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities. Appl Environ Microbiol (2007) 11.88

Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med (2005) 11.23

Microbes on the human vaginal epithelium. Proc Natl Acad Sci U S A (2005) 5.15

Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol (2004) 4.60

PRIMROSE: a computer program for generating and estimating the phylogenetic range of 16S rRNA oligonucleotide probes and primers in conjunction with the RDP-II database. Nucleic Acids Res (2002) 4.58

Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J (2007) 4.36

Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology (2004) 4.26

Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis. Clin Infect Dis (2008) 3.90

Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis (2005) 3.50

The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis (1993) 3.32

Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis (2004) 3.17

Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol (2007) 3.10

Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl Environ Microbiol (2008) 2.73

Vaginal lactobacillus flora of healthy Swedish women. J Clin Microbiol (2002) 2.67

Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis (2001) 2.49

Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J Clin Microbiol (2009) 2.29

Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis (2002) 2.09

Cultivation-independent analysis of changes in bacterial vaginosis flora following metronidazole treatment. J Clin Microbiol (2007) 2.06

Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG (2002) 2.01

Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis. J Infect Dis (2008) 1.99

Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol (2003) 1.89

Haemophilus vaginalis: vaginitis by inoculation from culture. Obstet Gynecol (1969) 1.87

How quantitative is quantitative PCR with respect to cell counts? Syst Appl Microbiol (2000) 1.82

Bacterial vaginosis in virginal and sexually active adolescent females: evidence against exclusive sexual transmission. Am J Obstet Gynecol (1988) 1.77

Gynecologic conditions and bacterial vaginosis: implications for the non-pregnant patient. Infect Dis Obstet Gynecol (2000) 1.74

Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women. Ann Intern Med (2008) 1.59

Comparison between Gram stain and culture for the characterization of vaginal microflora: definition of a distinct grade that resembles grade I microflora and revised categorization of grade I microflora. BMC Microbiol (2005) 1.55

Bacterial vaginosis. Transmission, role in genital tract infection and pregnancy outcome: an enigma. APMIS (2005) 1.32

Use of species-directed 16S rRNA gene PCR primers for detection of Atopobium vaginae in patients with bacterial vaginosis. J Clin Microbiol (2004) 1.26

Bacterial vaginosis--a disturbed bacterial flora and treatment enigma. APMIS (2005) 1.25

Enumeration of specific bacterial populations in complex intestinal communities using quantitative PCR based on the chaperonin-60 target. J Microbiol Methods (2005) 1.24

Rapid characterization of the normal and disturbed vaginal microbiota by application of 16S rRNA gene terminal RFLP fingerprinting. J Med Microbiol (2007) 1.22

Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR. Appl Environ Microbiol (2007) 1.17

Lactobacillus iners: a marker of changes in the vaginal flora? J Clin Microbiol (2007) 1.16

Bacterial vaginosis--a microbiological and immunological enigma. APMIS (2005) 1.15

Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real-time polymerase chain reaction study. Eur J Clin Microbiol Infect Dis (2008) 1.10

Real-time quantitative PCR for assessment of abundance of Pseudoalteromonas species in marine samples. Appl Environ Microbiol (2004) 1.08

Bacterial vaginosis--a laboratory and clinical diagnostics enigma. APMIS (2005) 1.01

Design and evaluation of 16S rRNA sequence based oligonucleotide probes for the detection and quantification of Comamonas testosteroni in mixed microbial communities. BMC Microbiol (2006) 0.90

High levels of Gardnerella vaginalis detected with an oligonucleotide probe combined with elevated pH as a diagnostic indicator of bacterial vaginosis. J Clin Microbiol (1992) 0.85

Recurrent bacterial vaginosis in a virgin adolescent: a new method of treatment. Infection (2002) 0.81

Articles by these authors

Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis (2005) 2.70

Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis (2004) 2.67

A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis (2009) 2.64

Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections. Sex Transm Dis (2005) 2.40

Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis (2009) 2.30

A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis (2002) 2.29

Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol (2003) 2.24

The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women. Sex Transm Infect (2011) 2.19

Patient-delivered partner treatment for male urethritis: a randomized, controlled trial. Clin Infect Dis (2005) 2.18

Exploring the diversity of Gardnerella vaginalis in the genitourinary tract microbiota of monogamous couples through subtle nucleotide variation. PLoS One (2011) 2.06

Cultivation-independent analysis of changes in bacterial vaginosis flora following metronidazole treatment. J Clin Microbiol (2007) 2.06

Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States. J Bacteriol (2004) 1.94

Sequence-based typing of Mycoplasma genitalium reveals sexual transmission. J Clin Microbiol (2006) 1.89

Predictors of serological cure and Serofast State after treatment in HIV-negative persons with early syphilis. Clin Infect Dis (2011) 1.88

Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard. J Clin Microbiol (2002) 1.85

The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and neisseria gonorrhoeae: the infected patient standard reduces sensitivity of single site evaluation. Sex Transm Dis (2004) 1.85

Measuring sex partner concurrency: it's what's missing that counts. Sex Transm Dis (2007) 1.73

Altered fecal microflora and increased fecal calprotectin in infants with colic. J Pediatr (2009) 1.70

An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun (2004) 1.69

Anal intercourse among young heterosexuals in three sexually transmitted disease clinics in the United States. Sex Transm Dis (2009) 1.68

Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID. Sex Transm Dis (2010) 1.59

From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex Transm Dis (2008) 1.58

Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection. J Infect Dis (2013) 1.56

Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis (2003) 1.56

Mycoplasma genitalium infections in asymptomatic men and men with urethritis attending a sexually transmitted diseases clinic in New Orleans. Clin Infect Dis (2002) 1.49

Cyanobacterial ecotypes in the microbial mat community of Mushroom Spring (Yellowstone National Park, Wyoming) as species-like units linking microbial community composition, structure and function. Philos Trans R Soc Lond B Biol Sci (2006) 1.49

Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J Infect Dis (2005) 1.46

Clinical evaluation of the BD ProbeTec™ Chlamydia trachomatis Qx amplified DNA assay on the BD Viper™ system with XTR™ technology. Sex Transm Dis (2011) 1.33

Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women. Clin Infect Dis (2008) 1.31

Mycoplasma genitalium: an efficient strategy to generate genetic variation from a minimal genome. Mol Microbiol (2007) 1.30

Prevalence and abundance of uncultivated Megasphaera-like bacteria in the human vaginal environment. Appl Environ Microbiol (2008) 1.29

When and where do youths have sex? The potential role of adult supervision. Pediatrics (2002) 1.27

Use of species-directed 16S rRNA gene PCR primers for detection of Atopobium vaginae in patients with bacterial vaginosis. J Clin Microbiol (2004) 1.26

Mycoplasma genitalium-encoded MG309 activates NF-kappaB via Toll-like receptors 2 and 6 to elicit proinflammatory cytokine secretion from human genital epithelial cells. Infect Immun (2008) 1.22

Use of home-obtained vaginal swabs to facilitate rescreening for Chlamydia trachomatis infections: two randomized controlled trials. Obstet Gynecol (2011) 1.21

A distinct cellular profile is seen in the human endocervix during Chlamydia trachomatis infection. Am J Reprod Immunol (2008) 1.20

Impact of patient characteristics on performance of nucleic acid amplification tests and DNA probe for detection of Chlamydia trachomatis in women with genital infections. J Clin Microbiol (2005) 1.17

Population-based genetic epidemiologic analysis of Chlamydia trachomatis serotypes and lack of association between ompA polymorphisms and clinical phenotypes. Microbes Infect (2006) 1.15

Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system. BMC Microbiol (2008) 1.14

Summary: The natural history and immunobiology of Chlamydia trachomatis genital infection and implications for Chlamydia control. J Infect Dis (2010) 1.12

Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women. J Clin Microbiol (2011) 1.09

PCR detection and analysis of the free-living amoeba Naegleria in hot springs in Yellowstone and Grand Teton National Parks. Appl Environ Microbiol (2003) 1.09

A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr (2010) 1.07

Education does pay off: pneumococcal vaccine screening and administration in hospitalized adult patients with pneumonia. J La State Med Soc (2004) 1.06

Vaginal swabs versus lavage for detection of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women. Sex Transm Dis (2005) 1.05

Legionella species diversity in an acidic biofilm community in Yellowstone National Park. Appl Environ Microbiol (2005) 1.05

Sexually transmitted infections and risk behaviors among African American women who have sex with women: does sex with men make a difference? Sex Transm Dis (2011) 1.05

Early repeat Chlamydia trachomatis and Neisseria gonorrhoeae infections among heterosexual men. Sex Transm Dis (2009) 1.04

Single-nucleotide polymorphisms in the rRNA operon and variable numbers of tandem repeats in the lipoprotein gene among Mycoplasma genitalium strains from clinical specimens. J Clin Microbiol (2004) 1.04

Genetic variation in the complete MgPa operon and its repetitive chromosomal elements in clinical strains of Mycoplasma genitalium. PLoS One (2010) 1.03

Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy. J Infect Dis (2012) 1.02

Histamine-2 receptor blockers alter the fecal microbiota in premature infants. J Pediatr Gastroenterol Nutr (2013) 1.02

Persistent Mycoplasma genitalium infection of human endocervical epithelial cells elicits chronic inflammatory cytokine secretion. Infect Immun (2012) 1.02

Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women. Sex Transm Dis (2010) 1.00

Management of women with cervicitis. Clin Infect Dis (2007) 0.98

The microbiota of the human genitourinary tract: trying to see the forest through the trees. Trans Am Clin Climatol Assoc (2012) 0.98

Safety and tolerability of Lactobacillus reuteri DSM 17938 and effects on biomarkers in healthy adults: results from a randomized masked trial. PLoS One (2012) 0.95

Chlamydia and gonorrhea co-occurrence in a high school population. Sex Transm Dis (2004) 0.95

Co-occurrence of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women. Sex Transm Dis (2011) 0.94

Introduction: The natural history and immunobiology of Chlamydia trachomatis genital infection and implications for chlamydia control. J Infect Dis (2010) 0.93

Detection of Naegleria sp. in a thermal, acidic stream in Yellowstone National Park. J Eukaryot Microbiol (2004) 0.92

Response to therapy following retreatment of serofast early syphilis patients with benzathine penicillin. Clin Infect Dis (2012) 0.91

Detection of human papillomavirus DNA in self-administered vaginal swabs as compared to cervical swabs. Int J STD AIDS (2003) 0.89

Risk behaviours by type of concurrency among young people in three STI clinics in the United States. Sex Health (2012) 0.86

Clinical evaluation of the BD ProbeTec™ Neisseria gonorrhoeae Qx amplified DNA assay on the BD Viper™ system with XTR™ technology. Sex Transm Dis (2012) 0.85

The major CD8 T cell effector memory subset in the normal and Chlamydia trachomatis-infected human endocervix is low in perforin. BMC Immunol (2012) 0.84

Mycoplasma genitalium infection activates cellular host defense and inflammation pathways in a 3-dimensional human endocervical epithelial cell model. J Infect Dis (2013) 0.84

Serum LDH level as a clue to the diagnosis of histoplasmosis. AIDS Read (2002) 0.84

Extensive variation and rapid shift of the MG192 sequence in Mycoplasma genitalium strains from patients with chronic infection. Infect Immun (2014) 0.82

The acceptability and behavioral effects of antibiotic prophylaxis for syphilis prevention. Sex Transm Dis (2003) 0.82

Missed opportunities for early detection of chlamydia and gonorrhea in school-based health centers. Sex Transm Dis (2006) 0.82

Comparison of methylene blue/gentian violet stain to Gram's stain for the rapid diagnosis of gonococcal urethritis in men. Sex Transm Dis (2011) 0.82

Characterization of the vaginal microbiota among sexual risk behavior groups of women with bacterial vaginosis. PLoS One (2013) 0.81

A framework for analysis of metagenomic sequencing data. Pac Symp Biocomput (2011) 0.81

The effects of chronic binge alcohol on the genital microenvironment of simian immunodeficiency virus-infected female rhesus macaques. AIDS Res Hum Retroviruses (2014) 0.80

Rapid plasma reagin titer variation in the 2 weeks after syphilis therapy. Sex Transm Dis (2012) 0.80

Variability of trinucleotide tandem repeats in the MgPa operon and its repetitive chromosomal elements in Mycoplasma genitalium. J Med Microbiol (2011) 0.80

Streptococcus pneumoniae soft tissue infections in human immunodeficiency virus. Am J Med Sci (2011) 0.79

Genetic diversity of Trichomonas vaginalis reinfection in HIV-positive women. Sex Transm Infect (2013) 0.79

Patient preference for patient-delivered partner therapy: exploratory findings from three sexually transmitted disease clinics. Sex Transm Dis (2011) 0.78

"Testing-only" visits: an assessment of missed diagnoses in clients attending sexually transmitted disease clinics. Sex Transm Dis (2013) 0.78

Chlamydia positivity in New Orleans public high schools, 1996-2005: implications for clinical and public health practices. Acad Pediatr (2013) 0.78

Screening methods for Chlamydia trachomatis and Neisseria gonorrhoeae infections in sexually transmitted infection clinics: what do patients prefer? Sex Transm Infect (2010) 0.77

Draft genome sequences of four axenic Mycoplasma genitalium strains isolated from Denmark, Japan, and Australia. J Bacteriol (2012) 0.77

Environmental distribution and seasonal prevalence of Mycobacterium ulcerans in Southern Louisiana. Appl Environ Microbiol (2013) 0.76

Does Antiretroviral Therapy Interfere With the Treatment of Trichomonas vaginalis Among HIV+ Women? Sex Transm Dis (2013) 0.76

Azithromycin Treatment Failure for Chlamydia trachomatis Among Heterosexual Men With Nongonococcal Urethritis. Sex Transm Dis (2016) 0.76

Rate of Decline in Nontreponemal Antibody Titers and Seroreversion After Treatment of Early Syphilis. Sex Transm Dis (2017) 0.75

The crab hole mosquito blues. Emerg Infect Dis (2011) 0.75

Vitamin D deficiency in HIV-infected and -uninfected women in the United States. J Acquir Immune Defic Syndr (2012) 0.75

Prevalence and treatment outcome of cervicitis of unknown etiology. Sex Transm Dis (2013) 0.75

Clinical case of the month. A 63-year-old woman with lumbago. Eikenella corrodens. J La State Med Soc (2014) 0.75

A Comparison of Single-Dose Versus Multidose Metronidazole by Select Clinical Factors for the Treatment of Trichomonas vaginalis in Women. Sex Transm Dis (2022) 0.75